首页> 外文期刊>JAMA: the Journal of the American Medical Association >Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial
【24h】

Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial

机译:Losmapimod对住院急性心肌梗死患者心血管结局的影响随机临床试验

获取原文
获取原文并翻译 | 示例
       

摘要

IMPORTANCE p38 Mitogen-activated protein kinase (MAPK)-stimulated inflammation is implicated in atherogenesis, plaque destabilization, and maladaptive processes inmyocardial infarction (MI). Pilot data in a phase 2 trial in non-ST elevation MI indicated that the p38 MAPK inhibitor losmapimod attenuates inflammation and may improve outcomes.
机译:重要事项p38丝裂原活化蛋白激酶(MAPK)刺激的炎症与心肌梗死(MI)的动脉粥样硬化,斑块失稳和适应不良过程有关。非ST抬高MI的2期试验的初步数据表明,p38 MAPK抑制剂losmapimod可减轻炎症并可能改善预后。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号